NovaBay Pharmaceuticals Inc. (NBY) Realizes Development Goals from Spanish Licensee
The developmental pharmacological world is a game of paying forward. Pay now and reap later. There is very little option until approvals of the US FDA are gained. If, however, the US FDA gives approval, exceedingly large profits can be had. NovaBay Pharmaceuticals Inc., a middle-stage developmental pharmaceuticals company, works to manufacture and market anti-infection products directed primarily (although not exclusively) at preventing infections within a hospital environment. The company works at the molecular level and has solid ties to larger operations that can offer financing and other marketing services. Perhaps the most beneficial aspect that the company brings to…